Gitto et al. transferred patient‐matched tumor‐infiltrating lymphocytes (TILs) to PDX models derived from three HGSC patients and found that the tumor burden was reduced after anti‐PD1 treatment.34 Here, PDCD1 is linked to neoplasm.